Condition
Minocycline
Total Trials
6
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
6Total
P 1 (3)
P 3 (1)
P 4 (2)
Trial Status
Completed3
Active Not Recruiting1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05512910Phase 4Active Not Recruiting
Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)
NCT04210713Phase 1Completed
Neuroimmune Dysfunction in Alcohol Use Disorder
NCT05474950Phase 1UnknownPrimary
Minocycline Treatment for Cystoid Macular Edema
NCT05474729Phase 1RecruitingPrimary
Minocycline for Chronic Autoimmune Uveitis
NCT00146809Phase 3Completed
Study About Efficacy and Safety to Treat Multi-System-Atrophy
NCT00409747Phase 4Completed
Minocycline to Treat Childhood Regressive Autism
Showing all 6 trials